It is known that diabetes is a disease that it is impossible to cure. However, after the discovery of insulin, this illness has no longer been regarded as deadly.
People suffering from this disease can live up to 69 years or even longer in some cases. Nevertheless, when diabetes meets heart disease, then it becomes highly dangerous. First of all, people suffering from diabetes are two or even three times more vulnerable to developing heart diseases than other people.
The latest research has shown that the combination of coronary artery disease and type 2 diabetes can lead to death. According to William B. White from the University of Connecticut, U.S., when this combination occurs, the patient needs extra care in order to prevent any possible cardiac event.
Worse, statistics showed that type 2 diabetes patients who were hospitalized for heart failure were given a 25% chance of dying over the next one and a half years. India, China, and the United States are the top three countries with the highest number of diabetic population.
More precisely, the number of people suffering from this disease in India has increased between 1980 and 2014 from 11.9 million to 64.5 million. Worse, the International Diabetes Federation Atlas recorded 69.2 million in 2015.
Scientists are still studying the connection between this illness and heart diseases to find the proper treatment that will prevent people from dying. Insulin, the hormone that our bodies naturally produce, is often needed as medication by patients with type 2 diabetes. Surprisingly, experts discovered that even insulin can contribute to the increased risk of developing heart diseases.
Furthermore, one of the leading causes that contribute to cardiac disease and diabetes include high cholesterol, hypertension, obesity and other illnesses. Plus, some types of medications used to control blood sugar were recently discovered as possibly harmful for the heart.
During the study, scientists analyzed 5,380 patients suffering from type 2 diabetes after they had a severe but not deadly coronary syndrome, such as unstable angina or heart attack. After they had been asked to take a placebo or alogliptin, they were followed for the following three years.
At the end of the study, there was no difference between the ones taking a placebo and the ones taking alogliptin. However, further research is needed for a proper treatment of this heart disease and diabetes combination.